向日葵跌2.03%，成交额1.19亿元，主力资金净流出2171.57万元

Group 1 - The core viewpoint of the news is that Sunflower's stock has experienced a decline in recent trading sessions, with a notable drop of 2.03% on January 7, leading to a market capitalization of 8.058 billion yuan [1] - As of January 7, the stock price is reported at 6.26 yuan per share, with a trading volume of 119 million yuan and a turnover rate of 1.45% [1] - The net outflow of main funds is 21.7157 million yuan, with significant selling pressure observed, as large orders sold 25.2535 million yuan, accounting for 21.29% of the total [1] Group 2 - Year-to-date, Sunflower's stock price has increased by 2.12%, but it has seen a decline of 2.03% over the last five trading days, 16.64% over the last 20 days, and 8.08% over the last 60 days [2] - Sunflower, established on March 21, 2005, and listed on August 27, 2010, focuses on the pharmaceutical sector, primarily in the research, production, and sales of anti-infection, cardiovascular, and digestive system drugs [2] - The company's revenue composition includes 73.44% from raw materials, 26.37% from formulated drugs, and 0.19% from other (non-main) sources [2] Group 3 - Sunflower has distributed a total of 204 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]